ArticleCancer cell international2026

Spatial transcriptomics and single-cell analyses reveal the role of the cisplatin-resistant gene panel in NSCLC progression and the tumor microenvironment, identifying LOXL2 as a potential therapeutic target.

Junzhi Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.